Michael Lichtenberg, MD, FESC

Three-Year Results from the MIMICS-3D European Union Study

Purpose: The BioMimics 3D Vascular Stent System (Veryan Medical) delivers a nitinol stent designed to provide optimal radial support, flexibility, durability, visualization and delivery a...

Michael Lichtenberg , MD, FESC;

01/21/2022

Lower-extremity intervention

The Arnsberg Registry: Thrombus Removal With the Aspirex Mechanical Aspiration Thrombectomy System

07/30/2023

Michael Lichtenberg , MD, FESC;

The intention of the Arnsberg Registry is to analyze the efficacy and safety of a mechanical thrombectomy device, the Aspirex Mechanical Aspiration Thrombectomy System (BD), in daily routine practice in patients with acute and subacute...

The intention of the Arnsberg...

07/30/2023

Cath Lab Digest

AMP 2022

Treatment of Post-PVI Acute Thrombosis, Lesion Preparation, Rotarex Trial Data, and More

09/16/2022

Michael Lichtenberg , MD, FESC;

Dr. Lichtenberg discusses some of his presentations at AMP 2022, which focus on lesion preparation and data from the Rotarex trial.

Dr. Lichtenberg discusses some...

09/16/2022

Vascular Disease Management

Video

Three-Year Results From the MIMICS-3D European Study: Clinical Outcomes for the BioMimics 3D Stent in a Real-World Population

05/04/2022

Michael Lichtenberg , MD, FESC;

Dr. Michael Lichtenberg presents 3-year results of the MIMICS-3D European Study.

Dr. Michael Lichtenberg presents...

05/04/2022

Vascular Disease Management

Acute Venous Intervention

The Use of the Aspirex™ Thrombectomy System for Iliofemoral Deep Vein Thrombosis

12/01/2022

Michael Lichtenberg , MD, FESC;

I think the greatest advantage of the Aspirex™ Thrombectomy System is its simplicity. You can just turn it on and aspirate the thrombus out.

I think the greatest advantage...

12/01/2022

Cath Lab Digest

ISET 2024

Final Subgroup Analysis From the Rotarex Post-Market Study

03/06/2024

Michael Lichtenberg , MD, FESC;

Dr. Michael Lichtenberg discusses his presentation on the Rotarex Post-Market Study at ISET 2024.

Dr. Michael Lichtenberg...

03/06/2024

Vascular Disease Management

AMP 2023

24-Month Results From the Prospective Multicenter Study of the Rotarex Atherectomy and Thrombectomy Catheter System

12/11/2023

Michael Lichtenberg , MD, FESC;

Dr. Michael Lichtenberg discusses his presentation on the latest results from a European trial analyzing the efficacy and safety of the Rotarex device (BD) for patients with femoropopliteal disease.

Dr. Michael Lichtenberg...

12/11/2023

Vascular Disease Management